Unknown PHASE2 INTERVENTIONAL 2-arm NCT01963442

Short Duration Treatment of Non-severe Community Acquired Pneumonia (PTC)

A Non-Inferiority, Multicentered, Controlled, Randomized, Double Blinded Study Investigating the Antibiotic Treatment Duration (3-day Versus 8-day) for Subjects Admitted to Emergency Services With Acute Non-severe Community Acquired Pneumonia (CAP)

Sponsor: Versailles Hospital

Conditions Community Acquired Pneumonia

Interventions Augmentin Beta-Lactams Chest X-ray Placebo (for Augmentin) blood sampling /Cell Counts/ C reactive protein (CRP)/Biochemistry

Updated 9 times since 2017 Last updated: Aug 11, 2017 Started: Nov 30, 2013 Primary completion: Jun 30, 2018 Completion: Jun 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01963442, this PHASE2 trial focuses on Community Acquired Pneumonia and remains ongoing. Sponsored by Versailles Hospital, it has been updated 9 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Sep 2019 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status

▶ Show 4 earlier versions

Jun 2018 — Sep 2019 [monthly]

Recruiting PHASE2
Sep 2017 — Jun 2018 [monthly]

Recruiting PHASE2
Feb 2017 — Sep 2017 [monthly]

Recruiting PHASE2
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE2

First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Versailles Hospital

Data source: Versailles Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Argenteuil, France , Boulogne-Billancourt, France , Clichy, France , Créteil, France , Garches, France , La Tronche, France , Le Chesnay, France , Le Kremlin Bicètre, France , Melun, France , Metz-Tessy, France and 6 more locations